AEON Biopharma AEON

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.04 (-5.63%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of AEON Biopharma (AEON)
    AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.6601

    • Market Cap

      $733,175.71

    • Price-Earnings Ratio

      0.00

    • Total Outstanding Shares

      1.11 Million Shares

    • Total Employees

      5

    • Dividend

      No dividend

    • IPO Date

      July 24, 2023

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      American Stock Exchange

    • Type

      Common Stock

    • Headquarters

      5 park plaza, Irvine, CA, 92614

    • Homepage

      https://www.aeonbiopharma.com

    Historical Stock Splits

    If you bought 72 shares of AEON before February 26, 2025, you'd have 1 share today.
    Execution DateSplit Amount
    February 26, 20251-for-72 (Reverse Split)

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow, Continuing$-11.02 Million
    Net Cash Flow$-11.02 Million
    Net Cash Flow From Operating Activities, Continuing$-30.69 Million
    Net Cash Flow From Operating Activities$-30.69 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Basic Earnings Per Share$9.70
    Preferred Stock Dividends And Other Adjustments$0
    Operating Expenses$-388.58 Million
    Operating Income/Loss$388.58 Million
    Nonoperating Income/Loss$-26.90 Million
    Net Income/Loss$361.68 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss$361.68 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss Attributable To Parent$361.68 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Wages$1.56 Million
    Current Liabilities$10.73 Million
    Fixed Assets$258,000
    Equity Attributable To Noncontrolling Interest$0
    Current Assets$2.37 Million
    Equity$-32.09 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AEON from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.